<unk>  is indicated as a postexposure prophylaxis for people at risk to develop hepatitis<unk> <unk> ecause they have<unk> een recently exposed to<unk> ody fluids of individuals who have hepatitis<unk> . This includes<unk> abies of mothers with hepatitis<unk> , sexual partners, healthcare workers, police and fire workers, and morticians. It provides a temporarily induced immunity<unk> y the transfer of immunoglobulins.<unk>  is given<unk> y either intramuscular (IM) or intravenous (IV) route, depending on the preparation. Side effects include allergic reactions,<unk> ack pain, general feeling of discomfort, headaches, muscle pain, nausea, and pain or<unk> leeding at the injection site. Allergy to human immunoglobulin is a contraindication. HIV has never<unk> een transmitted<unk> y<unk> . As with all<unk> lood-derived products, the transmission of prions is possible as a residual risk. Concomitant vaccination<unk>  should<unk> e given within 14 days of exposure to the hepatitis<unk>  virus. The half-life of<unk>  is about 3 weeks. In lieu of a<unk> ooster administration of<unk> , a hepatitis<unk>  vaccination is initiated at the time of the initial<unk>  administration, thus providing long term protection.<unk>  is classified as pregnancy category C substance<unk> y the U.S. Food and Drug Administration.
Hepatitis B immune globulin
Hepatitis B vaccine
Hepatitis C vaccine
Hepatitis A vaccine
Rabies immunoglobulin
Viral load monitoring for HIV
Vaccinia immune globulin
Hepatitis A and B vaccine